BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 14644857)

  • 1. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
    Leeb BF; Bird HA; Nesher G; Andel I; Hueber W; Logar D; Montecucco CM; Rovensky J; Sautner J; Sonnenblick M
    Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
    McCarthy EM; MacMullan PA; Al-Mudhaffer S; Madigan A; Donnelly S; McCarthy CJ; Molloy ES; Kenny D; McCarthy GM
    J Rheumatol; 2014 May; 41(5):931-7. PubMed ID: 24692520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.
    Nothnagl T; Leeb BF
    Drugs Aging; 2006; 23(5):391-402. PubMed ID: 16823992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A disease activity score for polymyalgia rheumatica.
    Leeb BF; Bird HA
    Ann Rheum Dis; 2004 Oct; 63(10):1279-83. PubMed ID: 15361387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
    Dasgupta B; Cimmino MA; Maradit-Kremers H; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Jensen HS; Duhaut P; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Nannini C; Cantini F; Macchioni P; Pipitone N; Amo MD; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazleman B; Silverman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Michet CJ; Marcus R; Gonter NJ; Maz M; Carter RE; Crowson CS; Matteson EL
    Ann Rheum Dis; 2012 Apr; 71(4):484-92. PubMed ID: 22388996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
    Proven A; Gabriel SE; O'Fallon WM; Hunder GG
    J Rheumatol; 1999 Jun; 26(6):1333-7. PubMed ID: 10381052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios.
    Binard A; De Bandt M; Berthelot JM; Saraux A;
    Arthritis Rheum; 2007 Apr; 57(3):481-6. PubMed ID: 17394219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of 2012 EULAR/ACR criteria for polymyalgia rheumatica to Korean patients previously classified by Chuang and Hunder criteria or Healey criteria.
    Park ES; Ahn SS; Jung SM; Song J; Park YB; Lee SW
    Int J Rheum Dis; 2018 Oct; 21(10):1838-1843. PubMed ID: 30168262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes in polymyalgia rheumatica.
    Matteson EL; Maradit-Kremers H; Cimmino MA; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Slott Jensen H; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Cantini F; Nannini C; Macchioni P; Pipitone N; Del Amo M; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazelman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Marcus R; Gonter NJ; Maz M; Crowson CS; Dasgupta B
    J Rheumatol; 2012 Apr; 39(4):795-803. PubMed ID: 22422492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA; Garcia-Porrua C; Miranda-Filloy JA; Martin J
    Drugs Aging; 2006; 23(8):627-49. PubMed ID: 16964987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica.
    Muratore F; Salvarani C; Macchioni P
    Reumatismo; 2018 Mar; 70(1):18-22. PubMed ID: 29589399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica.
    Kimura M; Tokuda Y; Oshiawa H; Yoshida K; Utsunomiya M; Kobayashi T; Deshpande GA; Matsui K; Kishimoto M
    J Rheumatol; 2012 Jan; 39(1):148-53. PubMed ID: 22174210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myalgia with Elevated Inflammatory Markers in an Obese Young Female: Fibromyalgia or Polymyalgia Rheumatica?
    Cheema R; Chang-Miller A; Aslam F
    Am J Case Rep; 2019 May; 20():659-663. PubMed ID: 31064976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus.
    Dejaco C; Duftner C; Cimmino MA; Dasgupta B; Salvarani C; Crowson CS; Maradit-Kremers H; Hutchings A; Matteson EL; Schirmer M;
    Ann Rheum Dis; 2011 Mar; 70(3):447-53. PubMed ID: 21097803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.
    Leeb BF; Rintelen B; Sautner J; Fassl C; Bird HA
    Arthritis Rheum; 2007 Jun; 57(5):810-5. PubMed ID: 17530664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymyalgia rheumatica].
    Kaposi Novák P; Schmidt Z
    Orv Hetil; 2006 Sep; 147(37):1791-802. PubMed ID: 17131799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methods for assessment of disease activity of polymyalgia rheumatica].
    Reisch M; Dejaco C
    Z Rheumatol; 2023 Jun; 82(5):368-379. PubMed ID: 37184675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance and agreement between different activity scores in polymyalgia rheumatica.
    D'Agostino J; Souki A; Lohse A; Carvajal Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel B; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A; Devauchelle-Pensec V
    RMD Open; 2024 Mar; 10(1):. PubMed ID: 38490696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of refractory polymyalgia rheumatica with etanercept: an open pilot study.
    Catanoso MG; Macchioni P; Boiardi L; Pipitone N; Salvarani C
    Arthritis Rheum; 2007 Dec; 57(8):1514-9. PubMed ID: 18050171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.